US FDA approves melt-in-your-mouth metoclopramide, Wilmington's first product
14 September 2009
Asher Mullard
Please Login to read the full article.
14 September 2009
Asher Mullard
asher.mullard@informa.com
The US FDA has given the green light to Wilmington Pharmaceuticals/ Salix Pharmaceutical's Metozolv ODT, an orally disintegrating formulation of metoclopramide HCl, for the treatment of diabetic gastroparesis and short-term gastroesophageal reflux disease (GERD).
Developed by Wilmington, rights...
Please Login to read the full article.
RELATED CONTENT
NEWS
- FDA warns about clogged oral syringes, feeding tubes with Teva's lansoprazole
- US FDA says fracture warnings not necessary for OTC PPIs
- P-CAB molecule moves ahead as Takeda looks to sustain GI franchise
- US Capitol Capsule: IOM analysis finds little evidence of vaccine harm, debunks autism link
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
